Bio-Rad outlines 2026 margin expansion and 0.5%-1.5% revenue growth guidance amid operational improvements [Seeking Alpha]
Bio-Rad Laboratories, Inc. Class B (BIO.B)
US:NYSE Investor Relations:
bio-rad.com/en-us/corporate/investor-relations
Company Research
Source: Seeking Alpha
Jonathan DiVincenzo, President & COO, stated that Bio-Rad delivered results within revised guidance for both revenue and operating margin, but "gross margin did not meet our expectations or frankly, what Bio-Rad is capable of delivering." He emphasized Newsletters for Every Investor Get daily, sector-specific newsletters packed with expert insights, fresh ideas, and new opportunities. Subscribe to Newsletters Sign Up Quick Insights Key headwinds include process chromatography declines, supply chain costs, and global trade/tariff uncertainty, leading to lower revenue guidance and margin pressure. QX700 sales drove strong ddPCR growth and market share gains, with further launches and innovation seen as core to future growth. Diagnostics shows mixed recovery due to product/geography mix, while process chromatography faces near-term declines and uncertainty amidst regulatory and vaccine demand changes. Recommended For You More Trending News
Show less
Read more
Impact Snapshot
Event Time:
BIO.B
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
BIO.B alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
BIO.B alerts
High impacting Bio-Rad Laboratories, Inc. Class B news events
Weekly update
A roundup of the hottest topics
BIO.B
News
- Greeley's Cascadia hockey stadium project tentatively blocked by voters, some say "a gut punch" for Northern Colorado [CBS News]CBS News
- ????????????:2024???2032????286??????374????????????3%??? [CNET News]CNET News
- Bio-Rad Laboratories (BIO) Returns To Profitability With Diagnostics Rebound – Is The Turnaround Durable? [Yahoo! Finance]Yahoo! Finance
- Assessing Bio-Rad Laboratories (BIO) Valuation After Prolonged Share Price Weakness [Yahoo! Finance]Yahoo! Finance
- Bio-Rad Laboratories Q4 Earnings Call Highlights [Yahoo! Finance]Yahoo! Finance